Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JOHNSON & JOHNSONJNJ · Entity 2722 | Exec VP, WW Chair, Cons Health | February 13, 2023 | February 16, 2023 |
| Kenvue Inc.KVUE · Entity 3098 | Director · Chief Executive Officer | March 10, 2025 | March 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JOHNSON & JOHNSON
Report date February 13, 2023 · Filed February 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,915.2661 |
Ending reported balance
After 2023-02-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-13 · Grant · Acquired 13,710 · Balance 72,345.2661 F1: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Row 2 · 2023-02-13 · Tax withholding · Disposed 6,430 · Balance 65,915.2661 |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $162.75 · Expires 2033-02-13 | Direct | 56,555 |
Reported balance
After 2023-02-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-13 · Grant · Acquired 56,555 · Balance 56,555 F2: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 3,417 |
Reported balance
After 2023-02-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-13 · Grant · Acquired 3,417 · Balance 3,417 F3: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F4: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.
F2: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
F3: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
F4: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.
Kenvue Inc.
Report date March 10, 2025 · Filed March 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 68,196 |
Reported balance
After 2025-03-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-10 · Grant · Acquired 68,196 · Balance 68,196 F1: These units correspond 1 for 1 with the Company's common stock. F2: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $23.92 · Expires 2035-03-10 | Direct | 569,040 |
Reported balance
After 2025-03-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-03-10 · Grant · Acquired 569,040 · Balance 569,040 F2: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These units correspond 1 for 1 with the Company's common stock.
F2: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2025 Filed Mar 12, 2025 22:53 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 569,040 | $0.00 Strike: $23.92 | $0.00 |
DisclosureSEC source: 0001944048-25-000084 · wk-form4_1741819986.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,040 Underlying: Common Stock · 569,040 shares Expires 2035-03-10 F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 22:53 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 68,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000084 · wk-form4_1741819986.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,196 Underlying: Common Stock · 68,196 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:01 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 32,968.51 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000057 · wk-form4_1741384878.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,935.01 Underlying: Common Stock · 32,968.51 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F3 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F4 · balance_after: Includes RSUs acquired as dividend equivalents. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:01 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 16,864 | $23.04 | $388,546.56 |
DisclosureSEC source: 0001944048-25-000057 · wk-form4_1741384878.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,469.35 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs). Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:01 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 32,968.51 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000057 · wk-form4_1741384878.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,333.35 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These units correspond 1 for 1 with the Company's common stock. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 139,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · derivative · entry 9 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 139,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level. F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: This award vested in full on 02/14/2025. F4 · derivative.expiration_date: This award vested in full on 02/14/2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 23,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · derivative · entry 8 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,195 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: This award vested in full on 02/14/2025. F4 · derivative.expiration_date: This award vested in full on 02/14/2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 70,038 | $21.75 | $1,523,326.50 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · nonDerivative · entry 6 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,364.84 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 139,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · nonDerivative · entry 5 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,402.84 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 11,865 | $21.75 | $258,063.75 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · nonDerivative · entry 4 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,232.84 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 23,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · nonDerivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,097.84 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · derivative · entry 7 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,438 Underlying: Common Stock · 8,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026 subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026 subject to the reporting person's continued service through the vesting date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 4,317 | $21.23 | $91,649.91 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,902.84 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-25-000023 · wk-form4_1739921383.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,219.84 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 23:37 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 7,322.84 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000170 · wk-form4_1733269053.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,644.71 Underlying: Common Stock · 7,322.84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date. F4 · balance_after: Includes shares acquired in dividend reinvestment transactions. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 23:37 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 3,746 | $24.08 | $90,203.68 |
DisclosureSEC source: 0001944048-24-000170 · wk-form4_1733269053.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,781.84 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 23:37 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 7,322.84 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000170 · wk-form4_1733269053.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,527.84 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:28 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 857,649 | $0.00 Strike: $19.01 | $0.00 |
DisclosureSEC source: 0001944048-24-000081 · wk-form4_1709854130.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 857,649 Underlying: Common Stock · 857,649 shares Expires 2034-03-05 F2 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:28 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 95,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000081 · wk-form4_1709854130.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,344 Underlying: Common Stock · 95,344 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000052 · wk-form4_1708036138.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,876 Underlying: Common Stock · 8,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: This award vests in three equal installments on 2/13/2024, 2/13/2025, and 2/13/2026, subject to the reporting person's continued service through such vesting date. F3 · derivative.expiration_date: This award vests in three equal installments on 2/13/2024, 2/13/2025, and 2/13/2026, subject to the reporting person's continued service through such vesting date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 4,317 | $19.34 | $83,490.78 |
DisclosureSEC source: 0001944048-24-000052 · wk-form4_1708036138.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,205 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:29 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000052 · wk-form4_1708036138.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 23,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000027 · wk-form4_1707783282.xml · derivative · entry 6 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,432 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F5 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award is fully vested. F4 · derivative.expiration_date: This award is fully vested. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionRestricted Stock Units · Derivative | 179,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000027 · wk-form4_1707783282.xml · derivative · entry 5 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 179,515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award is fully vested. F4 · derivative.expiration_date: This award is fully vested. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 11,986 | $19.67 | $235,764.62 |
DisclosureSEC source: 0001944048-24-000027 · wk-form4_1707783282.xml · nonDerivative · entry 4 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,084 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 23,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000027 · wk-form4_1707783282.xml · nonDerivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | Kenvue Inc. KVUE · Entity 3098 | Tax withholdingCommon Stock | 82,877 | $19.67 | $1,630,190.59 |
DisclosureSEC source: 0001944048-24-000027 · wk-form4_1707783282.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,638 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:14 UTC | Kenvue Inc. KVUE · Entity 3098 | Exercise / conversionCommon Stock | 179,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-24-000027 · wk-form4_1707783282.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 22:14 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 194,117 | $0.00 Strike: $20.81 | $0.00 |
DisclosureSEC source: 0001944048-23-000124 · wk-form4_1702332837.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,117 Underlying: Common Stock · 194,117 shares Expires 2033-12-07 F2 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 22:14 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 21,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000124 · wk-form4_1702332837.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,143 Underlying: Common Stock · 21,143 shares Expires not disclosed F1 · derivative.exercise_price: These units correspond 1 for 1 with the Company's common stock. F2 · derivative.exercise_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through such vesting date. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:31 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 880,424 | $0.00 Strike: $20.32 | $0.00 |
DisclosureSEC source: 0001944048-23-000094 · wk-form4_1696451483.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880,424 Underlying: Common Stock · 880,424 shares Expires 2033-10-02 F1 · derivative.exercise_date: This award will vest in full on 10/02/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 432,986 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 10 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,986 Underlying: Common Stock · 432,986 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 514,646 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 9 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,646 Underlying: Common Stock · 514,646 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 458,189 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 8 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,189 Underlying: Common Stock · 458,189 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantStock Options · Derivative | 418,970 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 7 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,970 Underlying: Common Stock · 418,970 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 179,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 6 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,515 Underlying: Common Stock · 179,515 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 139,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 5 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,170 Underlying: Common Stock · 139,170 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 156,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,417 Underlying: Common Stock · 156,417 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 23,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,432 Underlying: Common Stock · 23,432 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 23,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,195 Underlying: Common Stock · 23,195 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantRestricted Stock Units · Derivative | 25,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,314 Underlying: Common Stock · 25,314 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 3,417 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 56,555 | $0.00 Strike: $162.75 | $0.00 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,555 Underlying: Common Stock · 56,555 shares Expires 2033-02-13 F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 6,430 | $162.01 | $1,041,724.30 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,915.2661 Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 13,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002063 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,345.2661 F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001904 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 826 | $162.08 | $133,878.08 |
DisclosureSEC source: 0001225208-23-001904 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,635.2661 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001904 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Cons Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,461.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 10,033 | $115.67 Strike: $115.67 | $1,160,517.11 |
DisclosureSEC source: 0001225208-22-011500 · doc4.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,033 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 7,010 | $101.87 Strike: $101.87 | $714,108.70 |
DisclosureSEC source: 0001225208-22-011500 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,010 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.